Who
Michael Exton
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Lexicon Pharmaceuticals.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Jul 2024
- Last trade
- 28 Feb 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Feb 2026filed 3 Mar 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —503,263 | filing |
| 28 Feb 2026filed 3 Mar 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $301K204,831 at $1.47 | filing |
| 28 Feb 2026filed 3 Mar 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —503,263 | filing |
| 28 Feb 2026filed 3 Mar 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —503,263 | filing |
| 28 Feb 2026filed 3 Mar 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —503,263 | filing |
| 28 Feb 2026filed 3 Mar 2026 | LXRX Lexicon PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $301K204,831 at $1.47 | filing |
| 12 Feb 2026filed 17 Feb 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —862,440 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,293,670 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —862,440 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,293,670 at $0.00 | filing |
| 13 Feb 2025filed 18 Feb 2025 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,264,690 at $0.00 | filing |
| 13 Feb 2025filed 18 Feb 2025 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,509,790 at $0.00 | filing |
| 8 Jul 2024filed 8 Jul 2024 | LXRX Lexicon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,675,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.